ASCO Breakthrough: Scientific Innovations and Emerging Technologies in Cancer Care

ASCO Breakthrough: Scientific Innovations and...

Up next

Liquid Biopsy, AI, and Other Global Innovations From 2026 ASCO Breakthrough

Dr. Monty Pal and Dr. Roselle De Guzman discuss key abstracts from the 2026 ASCO Breakthrough Meeting, including the real-world impact of liquid biopsies for early multi-cancer detection, AI applications in colorectal cancer screening, and how global advances in breast, esophagea ...  Show more

Breast Cancer Highlights From ASCO26: OPTIMA, lidERA, and VIKTORIA-1

Dr. Megan Kruse and Dr. Hope Rugo discuss practice-changing data in metastatic breast cancer and critical shifts in the treatment of early-stage disease that were presented at the 2026 ASCO Annual Meeting. LINK TO FULL TRANSCRIPT 

Recommended Episodes

Ep. 178 ASCO 2024: Game-Changing GU Oncology Updates in Bladder and Kidney Cancers with Dr. Sumanta Pal and Dr. Petros Grivas
BackTable Urology

Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ...  Show more

#139 Justin Coombs, COO at AusHealth on Revolutionising Healthcare Through Innovation
Creating Synergy Podcast

What if the next big medical breakthrough was already sitting in a lab, waiting to be discovered?In this episode of Creating Synergy, we sit down with Justin Coombs, Chief Operating Officer at AusHealth, to dive into the groundbreaking advancements shaping the future of medicine. ...  Show more

Roche CEO: Future of cancer treatment, AI in Medicine and Trial Challenges
In Good Company with Nicolai Tangen

What’s next for cancer treatment and personalized medicine? How is AI reshaping the future of drug discovery? And can Europe keep pace with China’s rapid rise in health care innovation? In this episode, Nicolai welcomes Thomas Schinecker, CEO of Roche, one of the world’s large ...

  Show more

179. Back to Basics - Metastatic NSCLC feat. EGFR and ALK Driver Mutations
Oncology for the Inquisitive Mind

In this episode, Michael and Josh take a dive into the world of driver mutations, looking at two of the most clinically consequential: EGFR and ALK mutations. The work done in these areas has led to treatments that represent incredible advances over chemotherapy. How incredible? ...  Show more